http://grants.nih.gov/grants/guide/notice-files/NOT-OD-10-126.html


Status of Applications and Awards Involving Human Embryonic Stem Cells, and Submissions of Stem Cell Lines for Eligibility Consideration

Notice Number:NOT-OD-10-126
Key Dates

Release Date: August 30, 2010
Related Notices
Issued by

National Institutes of Health (NIH), (http://www.nih.gov)
Purpose
On August 23, 2010, the United States District Court for the District of Columbia issued a preliminary injunction in the matter of Dr. James L. Sherley, et. al. v. Kathleen Sebelius, et al. the National Institutes of Health that enjoins defendants, including the NIH, “and their officers, employees, and agents . . . from implementing, applying or taking any action whatsoever pursuant to the National Institutes of Health Guidelines for Human Stem Cell Research (“Guidelines”), 74 Fed Reg. 32,170 (July 7, 2009), or otherwise funding research involving human embryonic stem cells as contemplated by the Guidelines.”   As a result of the Court’s Order, the National Institutes of Health hereby issues the following notice regarding applications for grants and contracts that involve human embryonic stem cells (hESCs), and other matters related to implementation of the 2009 NIH Guidelines for Research Using Stem Cells:
Grant awards that were funded on or before August 23, 2010, are not affected by the preliminary injunction order, and award recipients may continue to expend the funds awarded to them prior to the date of the injunction.
Additional Information
For additional information see: http://stemcells.nih.gov/
 

Kind regards,

Theresa Defino
Editor
Report on Research Compliance
301-738-3721
xxxxxx@aol.com

Sample issue:
http://www.aishealth.com/SampleIssues/samplerrc.pdf

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================